Biotech · Private company
Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Track this companyFree. Adds Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- GefapixantPhase 2 · Osteoarthritis of the KneeClinicalTrials.gov · fetched Nov 12, 2026
- GefapixantPhase 2 · Idiopathic Pulmonary FibrosisClinicalTrials.gov · fetched Nov 12, 2026
- GefapixantPhase 2 · Bladder Pain SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- GefapixantPhase 2 · Refractory Chronic CoughClinicalTrials.gov · fetched Nov 12, 2026
- Sugar PillPhase 2 · Osteoarthritis of the KneeClinicalTrials.gov · fetched Nov 12, 2026
- GefapixantPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- OmeprazolePhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- An 8-Week Refractory Chronic Cough Study (MK-7264-021)PHASE2 · COMPLETED · started Dec 17, 2015ClinicalTrials.gov NCT02612623 · fetched Nov 12, 2026
- A Study to Assess the Tolerability of a Single Dose of Gefapixant (AF-219/MK-7264) in Subjects With Idiopathic Pulmonary Fibrosis (IPF)PHASE2 · COMPLETED · started Jul 20, 2015ClinicalTrials.gov NCT02477709 · fetched Nov 12, 2026
- A Multiple-Dose Pharmacokinetics Study of Two Gefapixant (AF-219/MK-7264) FormulationsPHASE1 · COMPLETED · started Jul 7, 2015ClinicalTrials.gov NCT02492776 · fetched Nov 12, 2026
- The Safety and Efficacy of Gefapixant (AF-219/MK-7264) in Female Participants With Interstitial Cystitis /Bladder Pain Syndrome (MK-7264-005)PHASE2 · TERMINATED · started Apr 13, 2012ClinicalTrials.gov NCT01569438 · fetched Nov 12, 2026
- A Four-Week Multicenter Study Evaluating the Safety and Efficacy of Gefapixant (AF-219/MK-7264) in Subjects With Osteoarthritis of the KneePHASE2 · COMPLETED · started Mar 29, 2012ClinicalTrials.gov NCT01554579 · fetched Nov 12, 2026